StemCell Therapy

Four things are at the very top of the list in most studies of health & longevity. The four take turns being #1. They are, in varying order: exercise, sleep, meditation (stress reduction), and diet / nutrition.

You can learn the basics of the first three in a few hours each, using tips here. Then if you simply do them, many of your life problems will be solved!

The last, diet/nutrition, you can spend the rest of your life on. You can learn and definitely get better at it, which I encourage. However, no one will never understand it fully. The scientific knowledge and the studies conflict, the rules change, each person is unique, and even when you find something that works for you, sooner or later, it wont. You have to learn, and adapt. Its worth it. (Oh, obviously get rid of bad habits like smoking, excess alcohol, etc, which are more or less in this category.)

However, there is a fair amount of agreement on eating habits to be found. As a scientist, I have spent decades researching this topic. Rather than go into detail on diet here, lets move on to the easy things.

Re exercise,Yoga, Tai Chi and older traditional forms appear to be better, but most anyexercise that keeps you moving, especially with complete range of motion and tonear exhaustion, will work if you do it regularly. Simple walking is ofbenefit too, as found in studies of people who sit at a desk for variouslengths of time. Longer sitters die younger, so get up occasionally and move.In fact, even passive motion confers significant benefits, by increasinglymphatic circulation.

Sleep is vastly underrated in modern society. Some people even brag about getting by with little sleep. Dont fall for it. Our ancestors got a LOT of it; they slept while it was dark, so they averaged around 9 hours, and certainly more than 6 hours. People who sleep well are statistically much healthier and live longer than other people. They are happier, they do better at work, and in their relationships. While studying nutrition, the more complicated topic, I kept finding these sleep studies. For just one example (of many), a study found that 6 hour sleepers are 4 times more likely to catch a virus than 8 hour sleepers. In these times, that is a stark warning.

There is more to learn about sleep, but it still isnt that complicated. I will post more in future articles.

I can mention one interesting thing here that you probably do not know; studies find that sleeping in motion produces the best quality sleep you can get, regardless of how many hours you have to sleep. Gentle motion produces faster sleep onset, more stage 3 sleep (the most desirable stage), and more sleep spindles (a measure of cellular repair). It produces better EEG (thus deeper relaxation while asleep, or even when awake), and has other benefits. Its far more enjoyable too. Of course as your own mother would tell you, it already worked for you.

There are several ways to benefit from motion during sleep. You can get a boat, a hammock, or other devices, if you can live with the drawbacks. Another technology to provide the most relaxing motion is a Floating Bed http://www.floatingbed.com There is a lot of science on this. It doesnt cost you precious time either, since falling asleep more easily and faster actually saves you time.

Meditation is the unsung hero here, butmost people wont take the time to do it, which is too bad. I encourage you tofind a simple technique that works for you. It works wonders for stress,health, and peace of mind. It feels nice, and it helps break the habit ofworrying so much.

Thats the basics of what you need to know to be healthy, happier, and have a long life. My hope for you is that you are happy and well, that you dont have any bad luck, and that you can do these things and that you enjoy a more beautiful life! Stay tuned for more.

View post:
How to achieve super health. - Thrive Global

Life expectancy in the U.S. rose slightly in 2018, after a few years of flagging. Add to that the frightening number of Americans who underestimate the average life expectancy. Then roll in what the U.S. Census says that 2030 will mark a tipping point at which older Americans will outnumber children and 1 in 5 people will be retirement age.

This recipe of numbers may present an opportunity for well-positioned marketers and entrepreneurs, but most importantly, it should serve as a wake-up call for people whose nest eggs might not be in the best shape. The takeaway for most Americans who are lucky enough to be able to save and invest is to ensure life expectancy is a facet of your financial and retirement planning and that it is accurate or even a bit overestimated. And in the case of aspects of your nest egg for which you personally dont determine life expectancy, find out what life-expectancy figure is used and how it was determined.

Behind The Slow Rise

In a wealthy and industrialized nation like the U.S., you might be surprised that life expectancy does not just steadily rise. But when you look at the big-picture numbers, youll see things like the opioid epidemic dinging life expectancy. The early 1990s even saw an actual decline in life expectancy in the U.S. due to the AIDS epidemic.

Bringing it home to a personal level, you of course might be part of a larger trend, but should more likely be focused on family health history and lifestyle factors when asking, Just how long will I probably live? For the most part, your genetics and family health are what they are, but you can affect changes in your health and longevity when it comes to lifestyle.

There are plenty of resources out there to help you assess and improve the factors you can. Apart from that, be prepared to take a clear-eyed look at your likely life expectancy and plan accordingly.

Estimating Expectancy

So, what are the right age expectancy numbers to work with? U.S. life expectancy (at birth) is 78.7. At age 65, a man can expect to live to 84 and a woman to 86.5. Again, there are many individual and environmental factors in play, but this gives you a ballpark idea of the real averages.

Retirement and financial planning sites tend to use life expectancy figures above those estimated by unbiased sources like the Social Security Administration. Again, its better to skew high on the expectancy, which in the best case means you have a nest egg cushion. Youll be ready to beat the odds with the third of Americans who make it past age 90 and even the one out of seven who make it to 95.

Seeing Silver

Lets focus now on the so-called Silver Economy: the aging U.S. population often touted for its spending power. On the flip side, the hope which for now seems to be warranted is that businesses are not just eager to serve seniors, but are adapting, growing and innovating to do so. This at first may just take the form of businesses managing marketing and messaging so that seniors feel well served. Next, those businesses are going to need the bandwidth to serve the larger volume of older Americans.

But where business and seniors both win is the nexus at which companies develop new ways of doing business, new products and even new industries to serve the onslaught of older customers. The accompanying shift in thinking should not be, What do seniors need? but What do people need? and then viewing that through a lens of the graying of America.

That broader perspective helps ensure seniors have not only more traditional senior services, but any and every other product and service they need and want. So, this would include not just skilled nursing care, for instance, but also day-to-day services and technology tailored to seniors.

Focusing This All On You

Make it a point to get at least a ballpark idea of your own life expectancy for retirement and planning purposes and find out how those handling things for you are making the same determination. Again, the idea is not to fixate on the inevitable, but to ensure your retirement and financial planning includes this important question: How long are you going to need your money to last?

For your own calculation, consider using a variety of longevity tools and then working with an average. You might choose one no-cost life expectancy calculator from a major life insurance provider, another from the Social Security Administrationand another thats very lifestyle oriented.

Keep your eye on the horizon to create or be served by opportunities that are evolving to serve the countrys aging population. From Gen Alpha and Gen Z up to and through boomers, who knows what products and services will be improved or invented as we roll to our newfound life expectancy?

The information provided here is not investment, tax or financial advice. You should consult with a licensed professional for advice concerning your specific situation.

Read the original post:
Know Your Life Expectancy And The Larger Implications - Forbes

Last week, in this space, I made reference to an Internet site that claims to predict longevity.

Its a reminder of the many breakthroughs the World Wide Web has provided.

Today, with a simple touch of the keyboard, you can find out what your credit score is, make reservations to fly to Paris, or pay your utility bill.

Or determine if your fiance has an arrest record, or discover you inherited a fortune from a Nigerian uncle you never knew you had.

And, now, even determine how many years you have left.

According to such longevity sites (there are numerous), all you have to do is provide some personal data and answer a number of lifestyle questions, and up pops your expiration date.

The best part of the exercise is that you can tweak your answers to buy additional time.

Most of the responses, such as your age, your parents longevity, or your health history, cant be altered. But there are a number of areas where adjustments can be applied.

Like diet.

If you stated, for example, that you tend to eat red meat and high-calorie foods, but replace those answers with high-fiber plant-based choices, the longevity numbers climb. Its actually a great tool to find areas where lifestyle changes can pay dividends.

In my case, after only a few modifications, I was able to add five years before the need to consider any sort of excavation.

And I can add two more by simply checking a particular box instead of the one I had originally selected.

Thats the one about gender.

Now Im wondering if I checked the right box, since, according to the site, women automatically get a two-year extension.

So its something I have to give some serious thought to. Its not that Im unhappy with my gender, but two years is two years, so Im not prepared to simply dismiss the idea of gender modification. Not if it means becoming the beneficiary of such a huge windfall. It just depends on whether its sufficient to simply declare the transformation or if surgery is involved.

But besides lifestyle changes, I have discovered another virtually foolproof way of prolonging life. It has to do with name selection. That may sound implausible, but the facts dont lie.

Take the name Bertha. I once saw it in an obituary, and it stated that the deceased had reached the age of 99.

Then I saw another such notice with the same name, only this time Bertha had passed at the age of 104.

At first, I thought it was a coincidence, but since then, every time I see a Bertha in an obituary, shes either near or beyond the century mark.

I had mentioned that to my wife when we were expecting our first child.

We hadnt selected a name yet, so I tried to convince her that if we named our child Bertha, there was an excellent chance the kid would live to be 100 or more.

But my wife is stubborn. She insisted we call him Christopher.

Contact humor columnist Irv Erdos at IrvErdos@aol.com.

Continue reading here:
Column: The real secrets to living longer - The San Diego Union-Tribune

Rocking a bejeweled crown and a fashionably-oversized pair of hot pink rhinestone-studded glasses, Pearle Williams held court Friday at Cornerstone Assisted Living in Vacaville.

Twas an early celebration of her 107th birthday, which is Saturday.

As an exuberant chorus of Happy Birthday swelled around her, the queen of the hour lounged in her wheelchair throne. All around her blush pink balloons waved, a memory board filled with photos served as a backdrop, a lushly frosted cake ringed with colorful roses beckoned and a huge roomful of friends, fellow residents and staff applauded.

I dont know what I owe my longevity too, Williams mused moments before she blew out her birthday candles and the singing started. Im not used to this.

Lourdes Dunham, Cornerstones activity director, fussed over her.

I had to bribe her, she admitted, about getting the spunky Williams to don the fanciful accessories, with this chocolate cake. She loves anything chocolate.

Seems the birthday girl was born in 1913 and grew up in Chicago. She was the oldest of three girls and outlived her sisters, Lillian and Sylvia.

She remembers the cold, living through a multitude of wars and the Depression, and the name of every American president. There were also weekend movies for a nickel and bags of popcorn for the same price.

Williams also told of fun Saturdays that involved dancing and a drink or two.

I liked a little bit of bourbon, she confided.

She married her sweetheart, who later joined the Navy. They would later have a son and a daughter, both of whom would give her her beloved grandchildren.

Williams told a wild tale of being pregnant with her son.

I was in labor, she recalled. Two women and a cousin took me (to the hospital). The bridge was out.

The other women were frightened and holding their breath, she continued, but everything turned out for the best.

These days, the youngster-at-heart enjoys simple pleasures.

I like to sleep, she said. Getting her hair done is also on her priority list.

Dunham shared that Williams is also a gamer.

Shes still playing bingo, still playing poker, the activity director said.

Her secret to longevity?

I inherited some good genes, she offered, adding that she also eats lots of fruits and vegetables.

Fellow residents and friends said her outlook is special.

Even when shes having a bad day, eventually she smiles and comes around, shared Betty Corison.

Shes always in good spirits, chimed in Rita McCain.

Louise Lester has known Williams for about seven years and said they formed a tight bond.

Pearle is just a great person. Shes a sweetheart, she said. Im proud to know her and be a friend of hers.

Follow this link:
With sparkle and glam, Vaca birthday girl toasts 107 - Vacaville Reporter

Michael Doyle achieved an incredible career milestone this month when he hit the 800 game mark - almost half of those in a Sky Blues shirt.

He admits it doesnt seem five minutes since he was on trial at Coventry City as a fresh-faced 21-year-old, unable to break through at Scottish giants Celtic in 2003.

Recommended by then Sky Blues assistant Eric Black, whod coached at Celtic Park, he caught the eye of then manager Gary McAllister in a couple of reserve team games at Highfield Road before being handed a contract and starting a long and affectionate relationship with the club.

He enjoyed eight years first time round and then made a triumphant return in 2017 to lead the club hed grown to love to promotion out of League Two.

I know when I got to 700 career games it was when I was at Coventry and the year we got promoted and I wasnt really aware of it, said Doyle , speaking to CoventryLive.

The 38-year-old is still going strong at Notts County where hes played over 30 games this term and showing no signs of slowing down with the club sixth in the National League and pushing for a return to League Two.

I always knew I was in high numbers but it wasnt until I hit 700 and a few of the lads were joking about it. So to be a year and a half or whatever it is down the line to get to 800, Im delighted but its not something that I really look at for myself.

I think its more other people picking up on it.

This is your round up of all things Coventry City; the one-stop shop that will keep you updated on the latest goings on at the club and beyond.

Transfers, injuries, match-days and managers, weve got you covered.

Well be bringing the very latest on the Sky Blues throughout the week and around the clock.

And you can get the latest sent to you through the CoventryLive WhatsApp service too.

Make sure you keep yourself updated with our handy daily catch up...

For all your latest CCFC news, opinion, analysis and transfer gossip, click here

You can follow our Sky Blues reporter Andy Turner on Twitter, and his email address is Andy.Turner@reachplc.com

Its a big achievement and its had a bit of publicity on the back of that, and Im really pleased but just enjoying playing.

Thats the most important thing, that I still enjoy playing and its not a struggle. My body isnt breaking down on me and thats the enjoyable part about it.

Theres clearly an element of natural fitness but whats the secret of longevity in football from a player who has managed to avoid serious injury for 20-odd years?

I have always looked after myself and enjoyed doing that in the summers and things like that, he said.

I have always trained hard when other people werent and I have always enjoyed keeping myself fit.

I enjoy getting out for a run in the close season. I wouldnt say its been easy for me but thats what I enjoy doing when I am away from the football. So that obviously helps, the fact that I enjoy doing it.

Theres one other secret that Doyle was adhering to meticulously years before it became the norm.

From when I first signed for Coventry some 18 years ago I was always big on hydrating, he said.

I was always drinking three or four litres of water a day and it obviously helps. I will be really hydrated most days and I have been for most of my career.

Its part of the job. You need to hydrate before and after training, and it helps your body recover, so its something I have always been massive on over the last 20 years.

Its rare youll see me without a bottle of water but thats the same for most players now. But I was doing that 18 years ago, always walking around with my big bottle of water.

If you want to be a footballer or any sort of sports person you have to look after yourself, make sure your diet is right and what youre eating and drinking is a given, you know. Because if you dont make the sacrifices you wont be able to do it at any level.

In his second season at Meadow Lane, the Irishman is showing no signs of hanging up his boots any time soon.

So is he good to go for another season?

Yeah, of course I am, he said confidently.

I have only missed ten games through suspension this season so thats down to myself. I havent missed any training and Im enjoying it.

I dont think Ill be retiring through my body letting me down. Its a case of so far so good and unless I am unfortunate to pick up a heavy injury which means I cant play and its long term then I will probably think, right, next stage of my life.

But at the minute I am just enjoying every minute.

I do consider myself very fortunate to still be playing regularly because I have a lot of friends whose bodies have let them down a long time ago and had to retire. So I feel very lucky.

Asked if his fondest memories of his Sky Blues career, which spanned 371 appearances and 26 goals, are getting promoted at Wembley in 2018, he said: Without doubt.

Listen, I probably took the first eight or nine years, not for granted, but we were a mid-table Championship club often fighting relegation and never had a run of the play-offs or anything like that.

The Championship is a big division and full of fantastic teams with big followings, and Coventry were as well, so it was an amazing time.

But going back is something I never really expected when I left Coventry but when I did, with the situation they were in, it was an amazing time to top it off by getting a promotion.

And that kind of cemented the bond I have with the club because I went back and achieved something, so that was nice and made the bond a lot stronger.

When he left for a second time, in January 2019, Mark Robins left the door open for him to return to the club in the future in a coaching capacity.

But thats certainly not on the agenda at this moment in time for the evergreen midfielder.

Listen, of course when I stop playing I certainly want to stay in the game, he said.

Thats what I want to do, be a coach or whatever and work in football.

Theres no doubt thats what I am going to do when I finish playing but right at the minute were trying to get ourselves promoted at Notts County.

We are in a good position and I am just fully focused on that to be honest with you.

Read more:
Cemented the bond - Legendary Coventry City skipper on amazing times, longevity and life after playing days - Coventry Telegraph

For the first time in the UK, there are more women aged 60 to 64 in work than not, according to an analysis of data from the Office for National Statistics.

The number of older women in work has increased by 51% since changes to the state pension age were introduced in 2010, the data reveals. This contrasts with an increase of 13% in the number of working men aged between 60 and 64 over the same period.

Experts have described the increase as seismic, with profound implications for the economy and for women in later life.

Supporting people aged 50 and over to remain in the workforce could add an additional 1.3% to GDP a year by 2040. But while it is an opportunity for some women, for others it is the culmination of inequalities that have built up over a lifetime, remaining in low-paid, insecure or poor quality work and delaying retirement through financial necessity,said Patrick Thomson, programme manager at the Centre for Ageing Better.

For many other women this will be a positive choice, with work providing financial independence, an opportunity to save for retirement, meaning and purpose, he added. The rising state pension age has clearly had an impact on womens working lives. But while longer lives and changing patterns of work mean many of us can expect to work for longer, its vital that people are able to be in work that improves their current and later lives.

Because of the delays to womens state pension, Julie Kumalinga is only able to retire because she can rely on her husbands pension. Aged 60, she is on a zero-hours contract as a passenger assistant for children with special needs. Before that, she spent a decade working for a care company that did not have a pension scheme.

If I was single, I wouldnt be able to afford to retire at all, she said. Its grossly unfair: no women should be forced into poverty in retirement.

Kathryn Morgan, a corporate business trainer aged 61, is keen to continue working. Morgan divides her time between the UK and teaching in Slovakia. I dont think I will ever retire as long as Im healthy, she said.

Stuart Lewis, founder of Rest Less, a jobs and volunteering site for over-50s, said: The rapid increase in the womens state pension age since 2010 has had a profound impact on women in their 60s: the employment rate of women aged between 60 and 64 has increased from 34% to 51% in just 10 years.

But as well as adjusting to the financial implications of the new state pension age, the added frustration for many comes from the continued challenge to find meaningful work in their 60s when age discrimination in the workplace remains all too prevalent, he added.

Patrick Thompson of the Centre for Ageing Better said: This is a seismic shift, with profound implications for the economy and for women in later life.

David Sinclair, the director of the UK International Longevity Centre, warned that while in recent decades there have been increases in employment levels of older people, we shouldnt get too excited.

The employment rates of men, for example, were actually higher in the 1960s. Weve got a long way to go if we want to maximise the longevity dividend, he said.

Too many older people are forced out of the workforce too early, whether that is due to ageism or poor health. Too many people want to work longer but cant, he added. Good work can be good for us. But if the additional jobs are not good jobs, we could be simply storing up problems for the future.

Caroline Abrahams, the charity director at Age UK, said: We are calling on the government to make sure they factor in the reality of life for middle-aged people before making any decisions about further raising the state pension age.

Age UK is firmly of the view that the triple-lock needs to stay in place, because it is not yet job done when it comes to eradicating pensioner poverty which is now on the rise yet again with 2 million older people living below the poverty line.

Read the original:
More women aged 60-64 in work than not for first time in UK ONS - The Guardian

(Photo : Aaron Yoo on Flickr)

Are you looking for a new mobile phone to buy? More than the price, you surely take the features on top of your priorities for your deciding factors. Some of the best choices you might want to include in your phones to buy are the newly-launched devices under the Galaxy S20 Series. This series of new devices offer new software features users might be looking forward to.

Recently, the tech company has revived the things users can do with their Galaxy S20 Ultra, S20 Plus, and S20, from restarting the devices to enabling gesture navigation, taking screenshots and more.

These latest updates are coming from a combination of the Android 10 OS of Google and the UI 2-software layer ofSamsung.

Along with these updates are man new features to identify. There may be a lot, but the 5 features and functions below are helpful enough to make you decide to buy (or not buy) the Galaxy S20 devices.

ALSO READ:iPhone 12's Supposed 'Killer Feature' Revealed: A Threat to Samsung's Galaxy S20?

If you already have the Galaxy S20, you will discover that the things you can do with your phone are more than just 5-there's a lot of them. The ones below though, are worth-trying. Surely, you will discover more as you navigate through this phone trying the features below.

AGalaxy S20 ownerclaimed, since she tried the new 'gesture navigation' feature, there's no way he'd go back to the custom navigation keys. Enabling the feature is so simple: from 'Settings,' look for the option, 'navigation type,' and opt for the 'full-screen gestures.' If you find the 'hints' choice unnecessary, you may disable it.

The 'power saving protocols' ofSamsung for One UIuse a behavior known as the "sleeping" app. Some users though are not that fond of it. For them, this "sleep" mode is causing the apps used infrequently to have severely restricted ability for the background to run. The main idea here is that the users who are installing several apps they don't even use, and those particular apps, together, are creating an "incremental battery drain" a number of their check-ins, and their "background processes" that compromises their phone's quality, durability and longevity. This feature may be an advantage for you though if you are not that techie enough to use a smartphone.

Samsung is known for allowing its users to startlingly few icons on theirhomescreen grid. However, with phones, now as large as they are, there really is no reason not to maximize the homescreen. Simply look for an empty area on your homescreen and "long-tap" on that area; tap the homescreen settings, set both your app and home screen layouts to the largest "5X6 configuration" to allow for more than enough space for a lot more activities on your phone.

If you are using the Google app, chances are, you are receiving weather notifications. If you are, you then, no longer need a secondary app, to send you a similar set of notifications just like how Google does. Just tap "settings", choose the "Weather" option, and disable or turn off all notifications for the Weather app. One thing for sure, it won't affect the weather widget on your homescreen. The needless and useless notifications about some information that you don't need as well are just prevented.

When theSmart alertis on, the phone vibrates every time the user picks it up for any new call or message that's coming in while the device is not in use. For many users of this smartphone, this is a bit bothersome. But if you a so busy and you tend to forget, or are not mindful of your phone all the time, this feature is for you. With the strong buzzing each time a new notification comes in, you definitely won't miss a single communication sent to you.

Go here to read the rest:
Make the Most Out of Your Samsung Galaxy S20: Here are 5 Things You Can Do - Science Times

Start Spring off by improving your health with asparagus. This Spring vegetable is not only a tasty seasonal treat. It also has intriguing health benefits. In fact, asparagus will start Spring off by giving you a quick folate boost. It ranks high up in this department along with broccoli and spinach. Better yet, the vegetable contains antioxidants including vitamin C and carotenoids, other vitamins, minerals and fibre. Therefore it is probably one of the most beneficial vegetables.

Interestingly, major studies state that when you eat lots of fruit and vegetables there is a much lower risk of mortality, especially death from cardiovascular disease. On average, each additional serving of fruit and vegetables a day reduced mortality risk by about 5%. But asparagus contains benefits that exceed most vegetables and fruits. It also has compounds that help regulate blood pressure. This might reduce hypertension risk which is a major factor in cardiovascular disease.

Other than its delicious flavor, asparagus can also help fight cancer. Its good for your brain and may even help you slim down. Theres no nutritionally dense vegetable quite like asparagus to start Spring off healthier. Just remember that its best to eat your asparagus as soon as you buy it. Pair it with lots of other spring vegetables and flavors. Were thinking peas, garlic or baby potatoes.

According to research, the health benefits of asparagus extend far. Apparently it can help promote ahealthy pregnancy, improved fertility, relief from the pre-menstrual syndrome, and improved bone health. Moreover, this yummy vegetable may even help you to manage conditions like diabetes, hangovers, cataracts, rheumatism, depression,neurodegenerative diseases, and convulsions. Better yet, it could also reduce the risk of urinary tract infections and blood cholesterol.

It is also brilliant for digestive health and has shown anticancer potential. You dont need to worry about your waistline either because just 1 cup of cooked asparagus contains only40 calories. It also provides you with 4 grams of protein, 4 grams of fiber and 404 milligrams of potassium. We need lots of Potassium in our bodies because it regulates blood pressure. Researchers state that asparagus also contains a compound called asparaptine, which helps improve blood flow and in turn helps lower blood pressure.

Besides tasting amazing, this spring veggie is filled with reasons to enjoy it with your meals. Lets explore some benefits and why you should eat more asparagus.

Start Spring right with this nutrient-packed vegetable. Experts explain that asparagus is an excellent source of fiber, folate, vitamins A, C, E and K, as well as chromium. This is a trace mineral that enhances the ability of insulin to transport glucose from the bloodstream into cells. So if youre trying to keep an eye on your blood sugar then this is great news for you.

For your information, asparagus is part of the herbaceous plant family. This includes avocado, kale and Brussels sprouts. Start Spring with asparagus because its especially rich in glutathione which is a detoxifying compound. This compound can help break down carcinogens and other harmful compounds like free radicals.

Thats why eating asparagus may help protect against and fight certain forms of cancer, such as bone, breast, colon, larynx and lung cancers.

Youll find that asparagus is one of the top-ranked fruits and vegetables for its ability to neutralize cell-damaging free radicals.

This is a great way to start Spring because it could help you slow the aging process and reduce inflammation.

Asparagus is an incredible addition to your cooking because it promotes a healthy brain which is key to living a happy, long life.

This is an integral anti-aging property. If you start spring with this delicious vegetable, you might help assist your brain in fighting cognitive decline. Like leafy greens, asparagus delivers folate, which works with vitamin B12-found in fish, poultry, meat and dairy-to help prevent cognitive impairment.

Moreover, studies using older adults with healthy levels of folate and B12 performed better on a test of response speed and mental flexibility. Therefore, if youre over age-50, then be sure youre getting enough B12. This is because your ability to absorb it decreases with age.

There are more studies demonstrating that asparagus racemosus is effective in reducing the risk of neurodegenerative diseases. Some of which include Alzheimers, Parkinsons, and Huntingtons diseases. Theyve linked these benefits to the presence of phytoestrogens in asparagus which have certain neuroprotective effects. Neurodegenerative diseases are genetic or periodic conditions affecting the neurons of the human brain. The issue is that the body doesnt normally have the ability to replace the damaged neurons.

As you may know, depression is forever increasing around the world. We need to do as much as possible to help alleviate some of its symptoms.

Scientific research is showing the efficacy of asparagus racemosus as an anti-anxiety and anti-depressant drug. You see, now you can also help start Spring off on a happier note. Asparagus may even help enhance memory, increase the production and secretion of estrogen, and revitalize and calm the nervous system. A pretty amazing way to start Spring, right?

Asparagus contains high amounts of a nutrient called inulin. This is a kind of complex carbohydrate, commonly known as prebiotic.It does not get digested until it reaches the large intestine, where it is fed upon by a kind of good bacteria like lactobacilli. Inulin aids in the improved absorption of nutrients.

Start Spring with asparagus because it is also packed with high levels of the amino acid asparagine. This acts as a natural diuretic. Increased urination not only releases fluid but helps rid the body of excess salt. This is especially beneficial for people who suffer from edema (an accumulation of fluids in the bodys tissues) and those who have high blood pressure or other heart-related diseases.

You might also be wondering why eating asparagus causes a strong urinary odor. Well, experts explain that asparagus contains a unique compound that, when metabolized, gives off a distinctive smell in the urine. Young asparagus contains higher concentrations of the compound so the odor is stronger after eating it.

Fortunately, there are no harmful effects, either from the sulfuric compounds or the odor. So you can happily start Spring by cooking with more asparagus!

When shopping the most common type of asparagus is green. However, you might find two others in supermarkets and restaurants: white, which is more delicate and difficult to harvest, and purple, which is smaller and fruitier in flavor. No matter the type you choose start Spring with this vegetable. Asparagus is a delicious, versatile vegetable that can be cooked in a variety of ways or enjoyed raw in salads.

A hectic lifestyle and poor diet affect the number of essential nutrients taken on a daily basis. Heres why eating good foodis the best way to get the right balance of vitamins and minerals.

5 Powerful Health Benefits of Asparagus You Probably Didnt Know. Eating Well. http://www.eatingwell.com/article/17129/5-powerful-health-benefits-of-asparagus-you-probably-didnt-know/

17 Impressive Benefits Of Asparagus. Organic Facts. https://www.organicfacts.net/health-benefits/vegetable/health-benefits-of-asparagus.html

Cancer: Treatments & Home Remedies. Organic Facts. https://www.organicfacts.net/home-remedies/home-remedies-for-cancer.html

Whats New And Beneficial About Asparagus? The Worlds Healthiest Foods. http://www.whfoods.com/genpage.php?tname=foodspice&dbid=12

The Unique Health Benefits Of Asparagus. Noted. https://www.noted.co.nz/health/health-nutrition/asparagus-the-unique-health-benefits

Follow this link:
Start Spring With More Asparagus In Your Cooking - Longevity LIVE

by Mary (Galer) Herschelman

In March 1920, a bootlegger from Panama spent $75,000 to build the Orpheum Theatre in downtown Hillsboro.

One hundred years later, the theater is still an iconic building in the downtown area where movie lovers of all ages meet to see the latest flicks.

According to current theater owner Jeff Eisentraut of Hillsboro, Jack JD Williams of Panama began construction on the building in the fall of 1919. Williams owned a speakeasy in Panama during the coal mine boom of that era.

Then Prohibition hit, Eisentraut said. Mr. Williams was a prominent bootlegger making his own alcohol and needed a place to spend some of his money. $75,000 went a long way back then.

At that time, the theater building was two stories, but featured only one movie screen with a balcony.

Eisentraut said Williams owned the business for only six months before selling it to Ed Fellis, the owner of the Opera House, which was also downtown.

He operated it as a movie theater until 1945, when he sold it to Frisina Theaters. It was later sold to Norman Paul of Carlinville in 1975. Paul operated the theater, along with several others in the area, until the 1990s, when he sold it to Gene Dickey, who operated it for a short while.

The Eisentraut family moved to Hillsboro in 2003, when Jeff heard a theater was available in the downtown area. Growing up in the theater business, Eisentraut and his family had previously owned and operated theaters in the Iowa area.

We had to find Hillsboro on the map, Eisentraut said with a smile. We came down in November of 2003 and 30 days later we moved in.

For a time, Jeff and his wife, Julie, resided in the upstairs apartment of the theater with their four children, Cary, Maddie, Alex and Bailey. Now, not only has their family grown to include spouses and grandkids, they have also added several theaters to the mix throughout the Midwest.

Now, the family is marking a special milestone in the very theater that brought them to town.

To celebrate such a historic event, the Eisentraut family is going to take moviegoers back in time. They will have a special event on Sunday, March 22, which is the day the theater opened 100 years ago.

Tickets for this special event are $.25, and are limited to four per person. The evening will include hors d oeuvres, as well as a Vaudeville-type show from the Imagine Hillsboro Theatre Group. Cary Eisentraut will serve as master of ceremonies, with remarks from Jeff Eisentraut and Hillsboro Mayor Brian Sullivan. Eisentrauts son-in-law, Chris Swed, will also perform card tricks.

Following the Vaudeville show, they will play Pollyanna, which is a silent film, and was one of the first to play at the Orpheum.

Eisentraut said for the first seven years of the theaters existence, movies were silent.

In addition to the special showing, they have joined the special #ShopHillsboro event that day with The Journal-News, the Hillsboro Chamber of Commerce and Imagine Hillsboro. Patrons who shop and eat downtown that day will have a chance to register for a special prize from the Orpheum, which is one-year season pass for the winner and a guest to the theater.

Businesses will also be encouraged to decorate their shop with a favorite movie theme. The Eisentrauts will pick a winner, and that business will be treated to a special, private screening of that movie.

And while the movies may have changed over the years, the Eisentrauts hope theatergoers still find the same thrill of going to the movies each and every time.

The thing that has given this theater such longevity is that people tend to remember moments that have happened here, Eisentraut said. Maybe they went to their first movie here when they were 15 or had their first date here. People may not remember the exact date, but the theater tends to be a marker in peoples lives.

See the article here:
Orpheum Theatre To Celebrate 100 Years - thejournal-news.net

Micky Bedell | BDN

Micky Bedell | BDN

Learning how to make food last longer can help limit trips to the grocery store.

As of 1 p.m. Friday, March 13, test results show that two Maine residents have tested presumptive positive for the coronavirus. Click here for the latest coronavirus news, which the BDN has made free for the public. You can support this mission by purchasing a digital subscription.

Now that the novel coronavirus has officially made its way to Maine, people have been stocking up on food, preparing for potential social distancing, self-isolation or self-quarantine. Canned and non-perishable foods especially have been flying off the shelves.

If you are worried about your stockpiles of more perishable food going to waste, there are ways to keep food fresher for longer. Besides, even though it is smart to stock up on pressure-canned beans, meat and vegetables and for long-term storage (here are some tips for organizing that stockpiled pantry, by the way), maintaining your health with fresh, healthy food is never more important than in the face of a global pandemic.

You can still go to the grocery store while practicing social distancing, self-isolation and self-quarantine, but the best way to keep yourself from getting sick is to avoid going out as much as possible. Here is a roundup of tips to make sure your food stockpiles will last as long as possible, and that you dont waste anything that might be valuable to use.

Sam Schipani | BDN

Mesh produce bags holding various forms of produce at the Hannaford's on Union Street in Bangor.

[Do you have questions about the coronavirus? Ask us here.](this was last shared on FB at 12pm Thursday)

Fruits and vegetables all have different requirements for storage. Some stay crisp in the refrigerator, while others will dry out in the cold. Produce, like apples, onions and tomatoes, emit a gas called ethylene as they ripen and should be kept away from produce like cucumbers, peppers and leafy greens that are sensitive to the gas and will spoil faster if stored with ethylene-emitting fruits and vegetables.

Here is a comprehensive roundup of the best way to store all different types of produce to make your fresh food stores last as long as possible.

Storing food in the freezer will not only prevent spoilage, but it will help preserve some of its quality. Here are some foods you didnt know you could freeze for longer storage. You can also save a range of foodstuffs in old ice cube trays to use for later, including broth, buttermilk and bacon drippings.

Though transmission of the novel coronavirus to persons from contaminated surfaces has not been documented, current evidence suggests that it may remain viable for hours to days on surfaces. If you do venture out to the grocery store, that means taking extra precautions while grocery shopping. Given the number of hands that dive in and dig around in produce bins, it would be wise to take extra precautions by washing your fruits and vegetables in a disinfecting wash. Heres how to make your own produce wash from white vinegar, water and lemon.

Hydrogen peroxide will give leafy greens an extra boost of freshness and longevity. Add one tablespoon of three percent hydrogen peroxide to a spray bottle filled with water and spritz your salad greens before returning them to the fridge. Wash thoroughly before eating to avoid any unpleasant tastes.

If you can get your hands on it, hydrogen peroxide is another way to make a produce wash. A simple combination of hydrogen peroxide and water serves as an inexpensive, Food and Drug Administration-approved, alternative to pricey fruit and vegetable washes. Add a tablespoon of hydrogen peroxide to a gallon of water to get rid of any lingering microbes when cleaning your produce. Rinse thoroughly before eating to avoid lingering flavors. Here are some other uses for hydrogen peroxide, as well as everything you need to know about cleaning with hydrogen peroxide.

Though canned beans are convenient, dried beans are cheaper, healthier and more sustainable than their canned counterparts. Proper storage will help them last without getting moldy or drying out. Heres how to properly store dried beans for maximum longevity.

After cooking, save the ends of the green onion bulbs with the roots attached. Place the bulbs root-end down in a small jar or glass and add enough water to cover the roots. Set the jar on a sunny windowsill, and, after about two weeks, your green onions will have formed long green shoots, and you will be ready to reap the rewards (yes, this trick works).

Leeks and fennel can be regrown with the same technique, though they take a little longer to grow. You can put the heart of romaine lettuce and the base of celery in water and it will regrow leaves. Many herbs including basil, mint and rosemary can also be placed in water to grow new roots and transfer to a pot of soil.

Reutilizing food scraps will make sure that nothing goes to waste. Here is how to make your own vegetable broth out of vegetable scraps, and how to make your own turkey broth out of a bird carcass (the same, more or less, goes for a chicken carcass).

Please dont replace the CDC recommendations for cleaning with only orange peels. If cleaning products are not available at stores and your house is getting a little stale after some time in self-isolation, citrus rinds can help freshen things up. Heres what you can do with all those leftover lemon, orange and lime peels.

Watch: Symptoms of the coronavirus disease

Original post:
Here's how to make your food last during the coronavirus - Bangor Daily News

Artificial Intelligence (AI) is getting increasingly sophisticated day by day in its application, with enhanced efficiency and speed at a lower cost. Every single sector has been reaping benefits from AI in recent times. The Healthcare industry is no exception. Here is decoding the future trajectory of healthcare with AI.

The impact of artificial intelligence in the healthcare industry through machine learning (ML) and natural language processing (NLP) is transforming care delivery. Additionally, patients are expected to gain relatively high access to their health-related information than before through various applications such as smart wearable devices and mobile electronic medical records (EMR).

The personalized healthcare will authorize patients to take the wheel of their well-being, facilitate high-end healthcare, and promote better patient-provider communication to underprivileged areas.

For instance, IBM Watson for Health is helping healthcare organizations to apply cognitive technology to provide a vast amount of power diagnosis and health-related information.

In addition, Googles DeepMind Health is collaborating with researchers, clinicians, and patients in order to solve real-world healthcare problems. Additionally, the company has combined systems neuroscience with machine learning to develop strong general-purpose learning algorithms within neural networks to mimic the human brain.

Companies are working towards developing AI technology to solve several existing challenges, especially within the healthcare space. Strong focus on funding and starting AI healthcare programs played a significant role in Microsoft Corporations decision to launch a 5-year, US$ 40 million program known as AI for Health in January 2019.

The Microsoft program will use artificial intelligence tools to resolve some of the greatest healthcare challenges including global health crises, treatment, and disease diagnosis. Microsoft has also ensured that academia, non-profit, and research organizations have access to this technology, technical experts, and resources to leverage AI for care delivery and research.

In January 2020, these factors influenced Takeda Pharmaceuticals Company and MITs School of Engineering to join hands for three years to drive innovation and application of AI in the healthcare industry and drug development.

AI applications are only centered on three main investment areas: Diagnostics, Engagement, and Digitization. With the rapid advancement in technologies. There are exciting breakthroughs in incorporating AI in medical services.

The most interesting aspect of AI is robots. Robots are not only replacing trained medical staff but also making them more efficient in several areas. Robots help in controlling the cost while potentially providing better care and performing accurate surgery in limited space.

China and the U.S. have started investing in the development of robots to support doctors. In November 2017, a robot in China passed a medical licensing exam using only an AI brain. Also, it was the first-ever semi-automated operating robot that was used to suture blood vessels as fine as 0.03 mm.

In order to prevent coronavirus from spreading, the American doctors are relying on a robot that can measure the patients act and vitals. In addition, robots are also being used for recovery and consulting assistance and transporting units. These robots are showcasing significant potential in revolutionizing medical procedures in the future.

Precision medicine is an emerging approach to disease prevention and treatment. The precision medication approach allows researchers and doctors to predict more accurate treatment and prevention strategies.

The advent of precision medicine technology has allowed healthcare to actively track patients physiology in real-time, take multi-dimensional data, and create predictive algorithms that use collective learnings to calculate individual outcomes.

In recent years, there has been an immense focus on enabling direct-to-consumer genomics. Now, companies are aiming to create patient-centric products within digitization processes and genomics related to ordering complex testing in clinics.

In January 2020, ixLayer, a start-up based in San-Francisco, launched one of its kind precision health testing platforms to enhance the delivery of diagnostic testing and to shorten the complex relationship among physicians, precision health tests, and patients.

Personal health monitoring is a promising example of AI in healthcare. With the emergence of advanced AI and Internet of Medical Things (IoMT), demand for consumer-oriented products such as smart wearables for monitoring well-being is growing significantly.

Owing to the rapid proliferation of smart wearables and mobile apps, enterprises are introducing varied options to monitor personal health.

In October 2019, Gali Health, a health technology company, introduced its Gali AI-powered personal health assistant for people suffering from inflammatory bowel diseases (IBD). It offers health tracking and analytical tools, medically-vetted educational resources, and emotional support to the IBD community.

Similarly, start-ups are also coming forward with innovative devices integrated with state-of-the-art AI technology to contribute to the growing demand for personal health monitoring.

In recent years, AI has been used in numerous ways to support the medical imaging of all kinds. At present, the biggest use for AI is to assist in the analysis of images and perform single narrow recognition tasks.

In the United States, AI is considered highly valuable in enhancing business operations and patients care. It has the greatest impact on patient care by improving the accuracy of clinical outcomes and medical diagnosis.

Strong presence of leading market players in the country is bolstering the demand for medical imaging in hospitals and research centers.

In January 2020, Hitachi Healthcare Americas announced to start a new dedicated R&D center in North America. Medical imaging will leverage the advancements in machine learning and artificial intelligence to bring about next-gen of medical imaging technology.

With a plethora of issues driven by the growing rate of chronic disease and the aging population, the need for new innovative solutions in the healthcare industry is moving on an upswing.

Unleashing AIs complete potential in the healthcare industry is not an easy task. Both healthcare providers and AI developers together will have to tackle all the obstacles on the path towards the integration of new technologies.

Clearing all the hurdles will need a compounding of technological refinement and shifting mindsets. As AI trend become more deep-rooted, it is giving rise to highly ubiquitous discussions. Will AI replace the doctors and medical professionals, especially radiologists and physicians? The answer to this is, it will increase the efficiency of the medical professionals.

Initiatives by IBM Watson and Googles DeepMind will soon unlock the critical answers. However, AI aims to mimic the human brain in healthcare, human judgment, and intuitions that cannot be substituted.

Even though AI is augmenting in existing capabilities of the industry, it is unlikely to fully replace human intervention. AI skilled forces will swap only those who dont want to embrace technology.

Healthcare is a dynamic industry with significant opportunities. However, uncertainty, cost concerns, and complexity are making it an unnerving one.

The best opportunity for healthcare in the near future are hybrid models, where clinicians and physicians will be supported for treatment planning, diagnosis, and identifying risk factors. Also, with an increase in the number of geriatric population and the rise of health-related concerns across the globe, the overall burden of disease management has augmented.

Patients are also expecting better treatment and care. Due to growing innovations in the healthcare industry with respect to improved diagnosis and treatment, AI has gained consideration among the patients and doctors.

In order to develop better medical technology, entrepreneurs, healthcare service providers, investors, policy developers, and patients are coming together.

These factors are set to exhibit a brighter future of AI in the healthcare industry. It is extremely likely that there will be widespread use and massive advancements of AI integrated technology in the next few years. Moreover, healthcare providers are expected to invest in adequate IT infrastructure solutions and data centers to support new technological development.

Healthcare companies should continually integrate new technologies to build strong value and to keep the patients attention.

-

The insights presented in the article are based on a recent research study on Global Artificial Intelligence In Healthcare Market by Future Market Insights.

Abhishek Budholiya is a tech blogger, digital marketing pro, and has contributed to numerous tech magazines. Currently, as a technology and digital branding consultant, he offers his analysis on the tech market research landscape. His forte is analysing the commercial viability of a new breakthrough, a trait you can see in his writing. When he is not ruminating about the tech world, he can be found playing table tennis or hanging out with his friends.

See the original post:
Decoding the Future Trajectory of Healthcare with AI - ReadWrite

Report Scope: The report provides a comprehensive summary of cloud computing for cell biology, genomics and drug design along with detailed profiles of key market players including a revenue product portfolio and recent activities.

New York, March 09, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cloud Computing in Cell Biology, Genomics and Drug Development" - https://www.reportlinker.com/p05873501/?utm_source=GNW The report analyzes trends and dynamics including drivers, limitations, challenges and opportunities.

The report discusses strategies adopted by emerging market players with recommendations for new market entrants.This research study discusses historical, current and potential market size.

The report will help market players and new entrants to make informed decisions about the production and export of goods and services, as well as providing organizations, distributors and exporters information about market development and trends.The study segments the market on the basis of applications and end uses.

A geographical market analysis is provided for all major segments.

Report Includes: - 43 data tables and 18 additional tables - An overview of the global market for cloud computing applications in cell biology, genomics and drug development - Analyses of global and regional market trends, with data from 2018 to 2019, and projections of compound annual growth rates (CAGRs) through 2024 - Assessment of market trends and opportunities, key developments and the impact of cloud computing technology on the biotechnology, pharmaceutical and healthcare industry verticals - Insight into recent developments in cloud infrastructure and information pertaining to key partnerships between cloud service providers and pharma/biotech companies and investment in pharmaceutical R&D sector - Discussion of the suppliers landscape, as well as the market positioning and strategies of key manufacturers and suppliers for cloud computing applications - Review of patent applications filed regarding cloud computing technology in the U.S. healthcare sector - Company profiles of the leading market players, including Amazon Web Services (AWS) Inc., Cisco Systems Inc., DXC Technology, Google LLC, Salesforce.com Inc., and SAP SE

Summary The global market for cloud computing in cell biology, genomics and drug development is estimated to grow at a CAGR of REDACTED during the forecast period.The market was valued at REDACTED in 2018 and is expected to reach REDACTED in 2024.

In biomedical research, cloud computing has resolved big data concerns and improves data, analytics, collaboration and sharing. Increasing biomedical research based on human, animal, plants, and microbes has increased the dependency on proper storage and network infrastructure as well as secure and scalable computing.

With growing big data concerns, researchers are inclined towards cloud computing platforms.These platforms provide flexibility to users to pay according to their usage of cloud services including software, hardware infrastructure and platforms to solve biomedical computation concerns.

The cloud offers ondemand storage and an analysis facility to users which makes it an emerging computing platform to address big data concerns.Owing to the flexibility and cost-effectiveness, cloud services are gaining significant importance in life science research for data storage, communication and collaboration with stakeholders.

On cloud platforms, large datasets and applications for gene sequencing, image analysis, protein folding and data mining can be shared for collaborative research between facilities.

The major pivotal factors contributing to the growth of the market include rising genomics and proteomics research and the increasing number of clinical trials performed across various countries.Considerable public and private investment in genomics and proteomics research is providing support to biotechnology start-ups and research institutes.

This helps healthcare providers to develop and commercialize genomics technologies and personalized medicines. Increasing U.S. FDA approvals for personalized medicines are supporting the growth in genomics research. For example, according to the Personalized Medicine Coalition, in 2018, approximately REDACTED of the REDACTED new molecular entities (NMEs) approved by the FDA are personalized medicines which constitute REDACTED of all new drug approvals. The Coalition classified REDACTED of NMEs as personalized medicines in 2017, REDACTED in 2015 and REDACTED in 2016. The U.S. FDA is making efforts to facilitate access to genomic testing and integration of real-world evidence into its regulatory framework. As a result, the FDA has begun to authorize the marketing of cancer-related genetic tests, and pharmacogenetics were allowed to be sold directly to the consumers. This has resulted in the development of personalized medicine as an emerging practice of medicine that utilizes the genetic profile of an individual to make appropriate decisions regarding prevention, diagnosis and treatment of the condition. Gaining complete knowledge about the patients genetic profile helps doctors to choose proper therapy or medication and to administer it with the proper regimen or dose. Significant data is generated by sequencing a single human genome which necessitates the adoption of cloud services. The 1000 Genomes Project is an effort to sequence genomes of at least a thousand people from across the globe to develop the most comprehensive and medically relevant picture of human genetic variation. This initiative intends to make genomic data easily accessible from international research institutions. Major support for the project is offered by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), Wellcome Trust Sanger Institute in Hinxton, England and the Beijing Genomics Institute, Shenzhen (BGI Shenzhen) in China.Read the full report: https://www.reportlinker.com/p05873501/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Story continues

Clare: clare@reportlinker.comUS: (339)-368-6001Intl: +1 339-368-6001

Original post:
Cloud Computing in Cell Biology, Genomics and Drug Development - Yahoo Finance

Revolutionary Gene-Editing Tool

Cardiovascular or heart disease (CVDs) is the leading cause of death across the world. Heart attacks resulting due to CVDs can cause death, and severe damage to cardiac muscle a muscle that forms the wall of the heart in survivors. However, researchers claim that they have discovered stem-cell activated mechanisms that promote healing after a heart attack.

According to the study by researchers from Mayo Clinic, stem cells were found to reverse the damage and restore cardiac muscle back to its condition before a heart attack. Human cardiopoietic cells obtained from stem cells within the bone marrow were found to hone in on damaged proteins and reverse intricate changes that a heart attack caused.

"The response of the diseased heart to cardiopoietic stem cell treatment revealed development and growth of new blood vessels, along with new heart tissue," said Dr. Kent Arrell, first author of the study, in a statement.

For the study, the researchers examined the diseased hearts of mice. The hearts of mice that received human cardiopoietic stem cell therapy were compared with those of that did not. Nearly 4,000 cardiac proteins were identified using a data science technique to map proteins found in the cardiac muscle. Over 10 per cent of the discovered proteins were found to suffer damage as a result of a heart attack.

"While we anticipated that the stem cell treatment would produce a beneficial outcome, we were surprised how far it shifted the state of diseased hearts away from disease and back toward a healthy, pre-disease state," said Dr. Arrell.

While the organs in the human body have the ability to repair their damaged cells, they may be unable to restore the loss entirely, and this holds good for cardiac cells as well. Dr. Andre Terzic, senior author of the study, said: "The extent of change caused by a heart attack is too great for the heart to repair itself or to prevent further damage from occurring."

He explained that upon the administration of cardiopoietic stem cell therapy to mice, a partial or complete reversal of nearly two-thirds of the damage caused by a heart attack was noted. Around 85 per cent of all cellular functional categories struck by the disease responded favorably to the treatment.

According to the World Health Organisation (WHO), CVDs claim nearly 18 million lives every year, which translates to 31 per cent of all deaths. The findings of the study provide an improved understanding of the restoration of heart health using stem cells and provide a framework for wider utilization of stem cell therapy for the treatment of various conditions.

Stressing that the actual mechanism behind the repair of diseased organs by stem cells is poorly understood, Dr. Terzic added: "This study sheds light on the most intimate, yet comprehensive, regenerative mechanisms paving a road map for responsible and increasingly informed stem cell application."

See the article here:
Stem cells can reverse damage caused by heart attack; repair mechanism discovered: Study - International Business Times, Singapore Edition

We live in a world of numerical benchmarks. Where numbers transcend the simple quantity they represent and instead become powerful markers for our society. We need look no further than Washington, D.C., to see how critical numerical benchmarks are in the way in which we govern ourselves: 268 electoral votes to win the presidency, 218 seats to control the House, 67 votes to override a presidential veto, 60 senators necessary to overcome a filibuster, and the list goes on. Sometimes, however, numerical benchmarks take on a much more human and personal significance. Sometimes numerical benchmarks are more than just ways in which we organize our society, sometimes they represent the accumulated differences between certain death and the hope of life.

In 2019, National Marrow Donor Program (NMDP)/Be The Match accomplished a feat that no one could even imagine when we began over 30 years ago 100,000 bone marrow transplants performed. This milestone is even more awe inspiring when you consider that only 50,000 transplants were facilitated over the first 25 years. It took just over seven years to double that number.

This is more than just a number, more than just an extraordinary achievement, each one of those 100,000 bone marrow transplants represents individuals with personal stories. Stories of life and death, of devastating sadness and overwhelming joy, and powerful reminders of the critical nature of the work of the entire transplant community.

Stories told by people like Katie and Jon Lanza. At just four-months-old, their son Nolan was diagnosed with a rare and often fatal genetic disorder, hemophagocytic lymphohistiocytosis (HLH). Symptoms of HLH include fevers, an enlarged spleen, low blood counts and liver abnormalities.

His only hope for survival was a bone marrow transplant.

Thats when Be The Match Registry stepped in, a match was found, and little Nolan had a transplant in May 2018, which saved his life.

As a physician, I do more than simply read about these powerful personal stories, I experience them first hand through my own patients. Patients like Lisa Maxson, a mother of three who found herself fighting for her life when diagnosed with acute myeloid leukemia at the age of 28. I understand all too well that life or death for that one patient I am treating can come down to finding that one donor. Fortunately for Lisa, that match was found and her life continues to be a testament to the Be The Match Registry.

As we celebrate this impressive benchmark, we honor the individuals and families who make up those 100,000 bone marrow transplants and the doctors, nurses, medical professionals and caregivers who are such an important part of this process. We also honor the visionaries who came before us. The men and women who, when told a national registry would fail, never gave up hope. Their vision became a reality and through collaboration, commitment, and compassion, we can now say that 100,000 volunteer donors have stepped up to help a stranger and millions more have joined the Be The Match Registry.

Be The Match Registry also stands out as an outstanding example of a highly successful public-private partnership between the federal government, Congress, NMDP, volunteers, patients, and families, our medical providers, and researchers. Showing that when we work together, we can accomplish almost anything.

Our work, however, is not done. We know that innovation must happen faster than ever, which is why we are not only celebrating 100,000 bone marrow transplants facilitated, we are also celebrating two significant acts of Congress last year that will help us achieve the next 100,000 transplants.

For the first time ever, Congress fully funded the C.W. Bill Young Cell Transplantation Program (Program), operated by NMDP/Be The Match, and gave Medicare patients expanded access to cellular therapy. Accomplished through bipartisan support, members of Congress stood up for blood cancer and blood disease patients in need of a donor and modernized Medicare reimbursement to ensure equal access.

Full funding by Congress means more donors will be added to the Be The Match Registry and more donors means more hope for the patient diagnosed with blood cancer or blood disease every three minutes of every day.

In addition to funding, the Patient Access to Cellular Transplant (PACT) Act (H.R. 2498/S. 1268) was signed into law in December. By fixing a reimbursement issue, this legislation expands Medicare beneficiaries access to bone marrow, peripheral blood stem cell, and cord blood transplants keeping families together by giving these patients the opportunity to access this life-saving treatment.

As survival rates from leukemia, lymphoma, and other forms of blood cancer soar to all-time highs thanks in part to rapid advancements in medical science and efforts from committed groups like NMDP/Be The Match we applaud Congress for stepping up and doing its part.

For transplant physicians like me, our focus is on individual patients. We work to help each person who comes to us hoping for a healthy future. By passing full funding and the PACT Act, Congress has helped thousands of patients at once with the stroke of a pen.

On behalf of the 100,000 patients who have received a transplant and for the next 100,000 whose survival will depend on cellular therapy, we say thank you to the members of the House and Senate for their vision and unwavering support.

Dr. Steven Devine is the Chief Medical Office for the National Marrow Donor Program/Be the Match Registry.

Link:
Behind the numbers of 100,000 bone marrow transplants and counting | TheHill - The Hill

We now know that COVID-19 is only mild to moderate for 80% of laboratory confirmed patients and about 6.1% patients get critical (respiratory failure, septic shock, and/or multiple organ dysfunction/failure), according to the joint WHO - China mission. Clearly, those who are in the critical stage are prone to death, most of them are aged more than 60, especially those with underlying conditions such as hypertension, diabetes, cardiovascular disease, chronic respiratory disease and cancer.

With 110,297 confirmed cases of COVID-19 and 3,840 deaths, more than 62,000 have recovered, as of Monday, March 9. The coronavirus is majorly transmitted through droplets and fomites via nose, mouth and eyes, during close unprotected contact between the infected and a normal person.

The majority consists of mild cases, and hence told ,Tom Inglesby, director of the Johns Hopkins Center for Health Security and an expert in pandemics and public health preparedness in a statement, "The more we diagnose mild cases, the more that will drive down the overall case mortality rate." The challenge is to identify mild cases, while severe cases are identified easily owing to symptoms.

In the case of the 6% who get critical, there is a "tipping point, where everything is going downhill and, at some point, you can't get it back," David Morens told news agency Bloomberg. Morens is the senior scientific adviser to the director of the National Institute of Allergy and Infectious Diseases, US.

The virus, at first, usually infects the nose. If it stays there, that's not fatal, but dangerous once it hits the lungs. Once it is down the windpipe to the peripheral branches of the respiratory tree and lung tissue, it take the patient to the critical stage (pneumonia-causing damage), explains Jeffery K. Taubenberger to Bloomberg who is the head of the viral pathogenesis and evolution section of the National Institute of Allergy and Infectious Diseases in Bethesda, Maryland

Normally, if white blood cells consume pathogens and help to heal damaged tissue as a body's immediate response, it can clear the infection, he adds. But damage would result in loss of protective mucus-producing cells as well as the tiny hairs, or cilia, that sweep dirt and respiratory secretions out of the lungs. "You have no ability to keep stuff out of the lower respiratory tract,"

Secondary bacterial infections are a great threat, in addition to coronavirus, as they kill the respiratory tract stem cells that enable tissue to rejuvenate,Taubenberger said adding that lungs would starve vital organs of oxygen like the kidneys, liver, brain and heart. "You just can't physically repair your lungs," he adds.

This is a cascading action. "When you get a bad, overwhelming infection, everything starts to fall apart in a cascade," said David Morens. Those among the 6% are prone to experiencing this "tipping point".

Continued here:
The 'tipping point' of death that coronavirus victims suffer and never return - International Business Times, Singapore Edition

Can you imagine needing a life-saving transplant and then having a family member, who is an exact donor match, denied entry into the U.S. for a medical procedure that could save your life? Or being denied your dying wish to see your foreign parent, sibling or child because they could not gain permission to enter the U.S.? For many patients, this is a harsh reality and a violation of their basic human rights.

For three years I was a lawyer with New York Legal Assistance Group (NYLAG) LegalHealth division and provided free civil legal services to New York City hospital patients with low income. Transplant teams sought my assistance when plans for a patients transplant were stalled after a family member who was an exact donor match had been denied a visitor visa to travel to the U.S. Palliative care teams sought my assistance for terminally ill patients who wished to see a family member before they died, but the loved one had been denied a visitor visa.

Whether a patients family member is able to secure a visitor visa is entirely at the discretion of the U.S. Department of State consular officer who is adjudicating the visa application. If the officer is not persuaded that the family member will return home after their temporary stay in the U.S., the officer will deny the visitor visa under Section 214(b) of the U.S. Immigration and Nationality Act. This law creates an automatic presumption that anyone who applies for a visitor visa actually intends to remain in the U.S. permanently. This presumption of immigrant intent can only be overcome if an applicant demonstrates sufficiently strong familial, social, professional and economic ties to a country other than the U.S.

Citizens of 38 (mostly European) Visa Waiver Program countries are not required to obtain visas for short visits to the U.S. In contrast, citizens of African countries and most Latin American and Asian countries are excluded from the Visa Waiver Program. As a result, patients of African, Latin American and Asian-descent have a much harder time bringing their family members to the U.S. for transplants and end-of-life companionship.

Most of my clients were experiencing poverty. Their family members often could not show proof of financial ties needed to overcome the presumption of immigrant intent. In such cases, I helped the seriously ill client request assistance from their elected representatives, who sometimes then engaged in quiet diplomacy with the State Department on behalf of the constituent. But even with the help of lawyers and elected officials, many visas are denied, and denials cannot be appealed.

The discretionary standard for evaluating immigrant intent is unjust and violates fundamental principles of human rights. The International Covenant on Civil and Political Rights (ICCPR), which the U.S. has adopted, states that no individual should be arbitrarily deprived of his or her life. It also recognizes that family is the fundamental unit of society and is entitled to protection by the government. These basic principles are violated when a patient dies waiting for a donor match to be allowed into the U.S., or is denied the comfort of being with close family before death.

The story of my client Jocelyn (whose name has been changed to protect her identity) illustrates the current systems flaws. Jocelyn was a naturalized U.S. citizen who became ill with an aggressive blood cancer in her early forties. Her sister in Guyana was determined to be an exact donor match for a stem cell transplant. As the caregiver for their aging mother, Jocelyns sister had no income and was unable to obtain a visitor visa. With no other viable donor source available, Jocelyn died awaiting a transplant.

A simple reform to current visa policy would prevent tragedies like Jocelyns from occurring. The discretionary standard for granting or denying a visitor visa should be dispensed with for two categories of visitor visa applicants:Those who are certified by a physician to be an exact donor match for a U.S. citizen or lawful immigrant, and the immediate family members of a U.S. citizen or lawful immigrant who has a terminal illness. A new emergency visa category should be created for these visa applicants, with its own set of conditions to minimize the risk of visitor overstays.

Bipartisan support for legislative and policy reform potentially exists. Just last fall, after congressional hearings and significant opposition, the Trump Administration reversed its decision to end medical deferred action, which allows undocumented immigrants suffering from life-threatening conditions to request to remain in the U.S. with authorization temporarily to obtain medical treatment that is unavailable in their home countries, without which they will likely die. Medical and legal communities had challenged the decision, arguing that no one should be denied life-saving medical treatment just because of their immigration status. The same commonsense notion applies here. Transplant candidates should not die because of the vagaries of consular officers, and terminally-ill patients should be able to die with dignity, surrounded by their loved ones, regardless of their familys origin. Reforming U.S. visitor visa policy by creating an emergency visa category for donor matches and close family of terminally ill patients would ensure that the fundamental principles of human rights and basic decency are respected.

Christina T.Holderis public interest counsel at Lowenstein Sandler LLP. She previously worked as a senior staff attorney at New York Legal Assistance Group.

View post:
US visa policy violates the human rights of transplant candidates and the terminally ill | TheHill - The Hill

Deals and Financings

Nanjing Legend Biotech, a subsidiary of GenScript (HK: 1548) (OTC:GNNSF), has filed for an IPO on a US exchange. In 2017, Legend surprised the world when its CAR-T therapy produced a 94% response rate in pretreated multiple myeloma patients. Six months later, Johnson & Johnson (NYSE:JNJ) partnered the treatment in a deal that paid Legend $350 million upfront, plus unspecified milestones and royalties. The CAR-T candidate, JNJ-4528, is now in Phase II trials in the US.

Harbour BioMed (HBM) raised $75 million in a Series B+ round to advance its clinical-stage compounds and portfolio of next-gen biotherapies for cancer and immunological diseases. The company builds its portfolio by in-licensings and via its proprietary Harbour Mice program. Harbour develops drugs for China and US markets, while it has entered partnerships to discover candidates for China companies Innovent (OTCPK:IVBIY) and BeiGene (NASDAQ:BGNE), along with other prominent global biopharmas. The company previously completed an $85 million Series B financing in August 2018. HBM is headquartered in Cambridge, MA, and it conducts R&D in Suzhou and Shanghai.

GenFleet Therapeutics (Shanghai) closed a $57 million Series B financing, co-led by CDH Investments and Shenzhen Capital Group. Founded in 2017, GenFleet is developing novel large and small therapeutic molecules for oncology and immunology targets. The company says its projects are potential first-in-class therapeutics with technical advantages and large markets. It will use the capital for ex-China development and clinical trials of its existing pipelines, plus expanding its immunology platform, working on new projects and building an industrial base.

Arctic Vision of Shanghai in-licensed greater China rights to Xipere, a treatment for macular edema associated with uveitis, from Clearside Bio (NASDAQ:CLSD) in a $35.5 million agreement. Founded last year, Arctic in-licenses breakthrough ophthalmology products for China. Xipere is its first deal. Arctic plans to acquire China rights to 3-5 products and then expand to a combination of global rights and internal discovery for additional drugs. Clearside, which is located in Alpharetta, Georgia, said Xipere is a proprietary suspension of the corticosteroid triamcinolone acetonide.

Exuma Biotech (formerly F1 Oncology), a Florida-Shanghai company developing CAR-T products for solid tumors, closed a $19 million Series B round. The financing included investments from MSD Partners and F1 BioVentures, plus conversion of notes held by individual investors. Exuma's Logic Gated CAR-T products become activated only when the target antigen and the tumor microenvironment are both present, reducing off-tumor side effects. The company has started clinical trials of two candidates. Exuma's Shanghai subsidiary oversees the company's development, manufacturing, and commercial units in Shanghai and Shenzhen.

OBiO Technology (Shanghai) completed a B+ Round of more than $15 million for its viral-based gene therapy CRO services and genetic drug CDMO/CMO services. Founded in 2013, OBiO collaborated with GE Healthcare (NYSE:GE) to establish the first domestic GMP viral production workshop in China and supply CRO/CDMO/CMO services for viral drugs. At the same time, OBiO is incubating gene therapy drugs for cancer therapy with three ADC candidates for oncotherapy that have proprietary IP. The B+ Round investors included GP Capital, Sinowisdom and Efung Capital.

Shanghai OPM Biosciences raised $14 million from China Life Medical Fund to support its CDMO service platform. The company offers serum-free media for cell cultures based on animal cells, as well as a full-range of cell culture development services. It customizes high-quality personalized animal cell culture media to optimize the cell culture process and reduce production costs. OPM has developed a variety of chemically defined CHO/HEK293 cell culture media and nutritional products. The company claims its media improve cell growth and expression.

China Immunotech Biotech of Beijing completed a $6.5 million Series A financing, led by Jianxin Capital with Grower Venture Capital and Huacheng Group participating. Founded in March 2018, China Immunotech is developing TCR-T and CAR-T products that target hematological tumors, solid tumors and virus-related diseases. It has two unique technology platforms, STAR-T and TCR-T. The STAR-T platform uses a proprietary structure of antigen receptor complexes. The company believes the platform provides multi-targeted molecules with better efficacy, fewer side effects and easier development than traditional CAR-T products.

Chengdu's HitGen has signed a licensing agreement to develop a novel class of drugs for Kaken, a Japanese (TK: 4521) specialty pharma. HitGen has already used its large library of small molecule and macrocyclic compounds to identify potential candidates. Few details were released, but Kaken is known to be concentrating its R&D on inflammation/immunology (dermatitis, rheumatoid arthritis and osteoarthritis), pain relief and fungal infections. One year ago, the two companies formed a similar collaboration, presumably for other targets. HitGen will receive an upfront payment and be eligible to receive preclinical and clinical milestones.

Suzhou Ascentage Pharma (HK: 6855) announced approvals for three clinical studies of APG-2575, a novel Bcl-2 inhibitor, two in the US and one in China. APG-2575 is an oral drug designed to treat several hematologic malignancies by blocking Bcl-2 to restore the normal apoptosis process in cancer cells. According to Ascentage, the candidate is the first China-made Bcl-2 inhibitor to start clinical trials. In its Phase I clinical studies, APG-2575 did not exhibit any dose-limiting toxicity or tumor lysis syndrome (which is commonly associated with other Bcl-2 inhibitors).

Denovo Biopharma, a San Diego-Beijing precision medicine company, has discovered a novel genetic biomarker for depression that it intends to use with DB104, a triple dopamine, serotonin and norepinephrine reuptake inhibitor. The company made the discovery using its proprietary biomarker discovery platform. Denovo licensed DB104 from Albany Molecular Research. Bristol-Myers Squibb (NYSE:BMY) returned the candidate to Albany after two Phase IIb clinical trials in treatment-resistant depression. The biomarker is one of four DeNovo biomarkers aimed at psychiatric use.

I-Mab (NASDAQ:IMAB), a Shanghai clinical-stage biopharma, has started to develop TJM2 (TJ003234) to treat cytokine release syndrome in severe cases of COVID-19. TJM2 is an I-Mab-discovered neutralizing antibody that binds human granulocyte-macrophage colony stimulating factor (GM-CSF), an important cytokine that plays a critical role in acute and chronic inflammation. By binding GM-CSF, TJM2 prevents downstream signaling and target cell activation, inhibiting other inflammatory responses. I-Mab intends to start clinical trials in the US and expand to countries especially hard-hit by COVID-19.

Mesoblast (NSDQ: MESO; ASX: MSB), an Australia-based regenerative medicine company, announced plans to start trials of remestemcel-L, its allogeneic mesenchymal stem cell (MSC) product candidate, in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19. The trial will be conducted in the US, Australia, China and Europe. ARDS is the principal cause of death in COVID-19 patients. In a small China trial, allogeneic MSCs cured or significantly improved all seven patients with severe COVID-19 pneumonia.

Ascletis (HK: 1672), a Hangzhou biopharma, reported that an initial group of 11 COVID-19 patients all recovered after being treated with a combination Ganovo and Ritonavir therapy. Ascletis's Ganovo, the first approved direct-acting anti-viral agent developed by a China company, was launched in 2018 to treat hepatitis C. Ritonavir is a generic anti-retroviral that is used in AIDS/HIV combination therapies. The small clinical trial was led by Dr. Hongyi Chen, the director of the Ninth Hospital of Nanchang.

Disclosure: None

Original Post

Editor's Note: The summary bullets for this article were chosen by Seeking Alpha editors.

Read the original here:
Week In Review: Nanjing Legend Files To Stage IPO In The U.S. - Seeking Alpha

Tom Hanks and his wife Rita Wilson have tested positive for coronavirus while working in Australia. USA TODAY

As the new coronavirus spreads and sickens more people in the USA, people with preexisting health conditions areat particular risk, public health officials say.

Actor Tom Hanks, who revealed that he was living with Type 2 diabetes in 2013, confirmed Wednesday that he and his wife tested positive for the coronavirus that causes COVID-19.

People with diabetes are among those at increased risk for complications from COVID-19, the Centers for Disease Control and Prevention says.

That's becausefluctuations in blood glucose levelsand possible diabetes complications can make it harder to treat a viral infection, the International Diabetes Federationsays.

The latest on coronavirus: EU rips travel ban; US stocks struggle; NBA suspends season; US death toll at 38

Though doctors are still learning what exactly puts someone at higher risk for developing a severe illness with COVID-19, early information indicates older patients and those with chronic medical conditions may be at higher risk.

According to early data frommore than 44,000 confirmed casesin China as of Feb 11, deaths among patients who had diabetes were at 7%, compared with 0.9% for those without an underlying condition, the CDC says.

According to theInternational Diabetes Federation, there may be two reasons for the complications that can arise.

"Firstly, the immune system is compromised, making it harder to fight the virus and likely leading to a longer recovery period," the group wrote in its "Diabetes Voice" publication. "Secondly, the virus may thrive in an environment of elevated blood glucose."

Q&A: You asked us tons of questions about the coronavirus. We answered them.

"Diabetes affects healing in general," said Dr.Susan Spratt, an endocrinologist at Duke University. Patients who have diabetes can have an increased risk of taking more time to heal and get a secondary infection, Spratt said.

People with diabetes can't make enough or can't as effectively usethe insulin in their bodies, according to the CDC. Insulin helps people use sugar in their bloodstreams for energy. As the food we eat breaks down into sugar, or glucose, it is released into our blood, and our pancreas releases insulin to facilitate the process.

"When there isnt enough insulin or cells stop responding to insulin, too much blood sugar stays in your bloodstream. Over time, that can cause serious health problems, such as heart disease, vision lossand kidney disease," the CDC says.

When a patient's diabetes is uncontrolled, meaning blood sugar levels are not in a recommended range, this can especially contribute to heart or kidney problems, said Dr. Maria Pea, director of endocrine services at Mount Sinai Doctors Forest Hills in New York.

Having both problems with their heart or kidney and diabetes could worsenthe prognosis for patients with COVID-19, she said.

Another potential issue for patients with diabetes amid the COVID-19 outbreak is inflammation, saidPea.

Increased blood sugar can increase inflammation, as can viral infections,Pea said. With bothincreasinginflammation, this can increase the likelihood of a more severe complication, she added.

People with diabetes, even those with the condition well managed, are at a higher risk of complications from the flu as well, the CDC says.

Patients with Type 1 diabetes, caused when a person's immune system attacks the cells in their pancreas that create insulin, are at an increased risk fordiabetic ketoacidosis. "This can make fluid and electrolyte management even trickier when trying to manage sepsis," Spratt said.

According to research published Wednesdayin the medical journal The Lancet, sepsis and septic shock are among the severe complications observed in some COVID-19 cases.

The CDC recommends people with preexisting conditions take everyday precautions to protect themselves from COVID-19. This includes avoiding contact with sick people, washing their hands regularly and not touching their face, among other measures.

Those who have a condition such as diabetes should make sure they're in contact with their doctor if they need extra medication or supplies, such astest strips or insulin.

The American Diabetes Associationrecommends gatheringsimple carbs such asregular soda, honey, jam,Jell-O, hard candies or popsicles.

"If you have diabetes and you have symptoms such as cough, high temperature and feeling short of breath, you need to monitor your blood sugar closely," Dan Howarth, head of care at Diabetes UK, said in a statement.

Follow USA TODAY's Ryan Miller on Twitter @RyanW_Miller

Autoplay

Show Thumbnails

Show Captions

Read or Share this story: https://www.usatoday.com/story/news/health/2020/03/12/tom-hanks-coronavirus-actor-has-covid-19-diabetes-heres-risk/5030111002/

Original post:
Why people with diabetes, like Tom Hanks, may be at increased risk of coronavirus - USA TODAY

Bossier, La. - More than 7-million American adults have diabetes and don't know it. That's about one in four people. And with diabetes, what you don't know can kill you.

There is absolutely no way to tell who in this crowd has diabetes, "You don't just go to bed one day and wake up the next and you're diabetic," says Endocrinologist, Laura E. Kimball-Ravari, M.D.

There are symptoms that go unnoticed leaving one-third of diabetes cases undiagnosed, "Changes and differences in your body from having high blood sugars can start early on," says Ravari. She adds, the sooner a person discovers they're diabetic the better.

"Diabetes is the leading cause of blindness in adults, the leading cause of kidney failure requiring hemodialysis, the leading cause of lower limb amputation," says Ravari.

Tiffany McCallister was just a toddler when her mother suspected something might be wrong, "She took me to the doctor and they said there was nothing wrong."

At that time, blood glucose tests weren't as accurate. Her mother got a second opinion, "And immediately smelled my breath and said she's a diabetic."

Tiffany has Type1. Diabetes typically considered the type that affects children, "But, they can also be diagnosed when they're much older, even 30's and 40's. But, they're usually a more slender build and are normally more fit," adds Ravari.

Still the first step is diagnosis which means knowing the symptoms. "You do have to look for the symptoms of diabetes, and some of the symptoms are being very hungry, being very tired, and maybe having some blurry vision," says Ravari.

Frequent urination is also a symptom. A person might also have cuts that don't properly heal.

Diagnosed as a toddler, to Tiffany managing diabetes is a way of life. Whether you're a Type 1 or Type 2 diabetic, going undiagnosed could be deadly, "I've had it a long time. And the best thing, take care of yourself and don't limit yourself."

If you are experiencing any of the symptoms - make an appointment with a doctor. The longer diabetes goes undiagnosed, the more damage it can cause. Prevalence of the disease is expected to increase by 54-percent in the next 10 years.

More:
Defeating Diabetes: What you don't know can kill you. Take the test - KTBS

PUNE, India, March 13, 2020 /PRNewswire/ -- Infinium Global Research has recently published a global report on "Artificial Intelligence in Diabetes Management Market(Device - Insulin Delivery Devices, Diagnostic Devices, and Glucose Monitoring Devices): Global Industry Analysis, Trends, Size, Share and Forecasts to 2024", the reported study estimated the market for artificial intelligence in diabetes management will reach up to USD 1264.7 million by 2024, with a compound annual growth rate of 47.5%, in the forecast period (2018-2024).

Digitization has made big data technologies more relevant in the healthcare environment. The propagation of smart devices has enhanced the transition to digitized healthcare. The smart apps have made self-management of diabetes by the patients affordable. Sensors are proficient in transmitting data to smart devices and diabetics can monitor their blood glucose levels on these devices. Pharmacogenetics and machine learning will help systems embedded with artificial intelligence to manage diabetes better than humans in the near future. Artificial intelligence algorithms bring about advanced glucose prediction methods that help in tackling diabetes effectively.

Furthermore, artificial intelligence is leveraging the avalanche of healthcare data and is improving patient outcomes for diabetes patients. Machine learning algorithms allow better diagnosis and monitoring resulting in enhanced patient-centric treatment. It is predicted that diabetes will extensively be managed by smart machines and artificial intelligence algorithms over the forecast period.

Download Exclusive Sample Copy of Report: https://www.infiniumglobalresearch.com/reports/sample-request/3241

Increasing Prevalence of Diabetes Globally

Diabetes is a medical condition wherein the inability of the pancreas to produce insulin causes augmented glucose levels in the body. Presently, the major part of the world is suffering from type 2 diabetes to a greater extent. Furthermore, genetics and an unhealthy lifestyle are considered as major causes of diabetes mellitus. Diabetics face various daily challenges such as dietary restrictions and regular administering of insulin. The anytime-anywhere nature of digital technology allows patients to address their health problems by connecting with the healthcare team and sharing data. This is creating a digital ecosystem of data driven tools that can associate patients and their care team for better management of diabetes.

Moreover, the government programs are running across the world in order to control diabetes. Numerous software companies come with an idea of several applications in diabetes management which would help in controlling and managing diabetes. Growing use of mobile phones permits these companies to design apps which directly or indirectly help to manage the diabetes mellitus.

Increasing Penetration of Connected Devices and other Wireless Technology Will Spur Revenue Growth

The global artificial intelligence in diabetes management market is anticipated to witness the exceptional growth during the estimated period. The growth is primarily associated with the increasing prevalence of the geriatric population across the globe. In addition, the rising prevalence of metabolic disorders together with increasing adoption of a torpid or sedentary lifestyle also contributes to boosting the growth of artificial intelligence in the diabetes management market.

However, few factors such as government regulation, a dearth of awareness, and high cost are the major restraints limiting the growth of artificial intelligence in the diabetes management market. Nevertheless, various research and technological developments are considered as better opportunities that help in bringing new growth paths for artificial intelligence in the diabetes management market over the forecast period.

Novel Solutions Offered by Several Companies and Digital Health Start-Ups Assist in Revenue Growth

The key players are investing in integrated Artificial Intelligence technology with other technologies such as the Internet of Things (IoT), Natural Language Processing (NLP), and Machine Learning (ML). Launch of the technologically advanced and economical system by key players in the market are projected to propel the growth of the market during the forecast period. Various companies are also providing a wide range of devices and software portfolio to offer advanced solutions to their customers.

Furthermore, mergers & acquisitions, strategic partnerships, collaboration, and agreement are some of the major strategies adopted by industry vendors to sustain competition in the market. For instance, in June 2019, Companion Medical, a leader in the development of advanced insulin delivery technology to improve diabetes care, and Glooko, a leader in diabetes data visualization and management, have declared an incorporated data partnership agreement that will permit insulin data from users of the InPen Smart Insulin Injection Pen to be integrated into the Glooko Enterprise diabetes data management system and Glooko Mobile App. This amalgamation will assist users to automatically incorporate their insulin data with the Glooko diabetes data management system for medical evaluation by their healthcare professionals.

Evolving Healthcare Infrastructure in Developing Nations Enables Market Growth in Asia Pacific

North America region is estimated to remain its dominance in artificial intelligence in the diabetes management market during the prediction period due to growing innovation in artificial intelligence-based solutions. Furthermore, North America is in the next phase of digitization of concepts like the Internet of Things, big data, robotics, and machine learning. Consequently, these digital technologies are expected to drive the regional market over the projection period. The Asia Pacific region is anticipated to witness an enormous growth in the near future owing to new product launches and a huge diabetes population base.

In addition, the Asia Pacific region is also witnessing numerous product launches. For instance, in May 2019, Roche Diabetes Care India introduced its Integrated Diabetes Management Solution (IDMS) program in India along with the introduction of the Accu-Chek Instant blood glucose monitoring (BGM) system and the My Sugar app. Moreover, the government of China is promoting the development of artificial intelligence in the healthcare sector and offering funds for smart healthcare facilities.

Need Assistance? Send an Enquiry@ https://www.infiniumglobalresearch.com/reports/enquiry/3241

Global Artificial Intelligence in Diabetes Management Industry Coverage

Chapter - 1 Preface

Chapter - 2 Executive Summary

Chapter - 3 Global Artificial Intelligence in Diabetes Management Market Overview

Chapter - 4 Artificial Intelligence in Diabetes Management Market Macro Indicator Analysis

Chapter - 5 Global Artificial Intelligence in Diabetes Management Market by Device

Chapter - 6 Global Artificial Intelligence in Diabetes Management Market by Region 2018-2024

Chapter - 7 Company Profiles and Competitive Landscape

Browsein-depth TOC on "Artificial Intelligence in Diabetes Management Market"

About Us

Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes and non-profit/non-government organizations to meet their knowledge and information needs.

Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide the knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations and environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.

Contact:

Mr. Shrikant AthavaleInfinium Global ResearchOffice No. 103 and 104,Suratwala Mark Plazzo,Hinjawadi, Pune,Maharashtra,Pin- 411057.USA: 1-888-500-3114Email:info@infiniumglobalresearch.com Research Insight:https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-artificial-intelligence-in-diabetes-management-marketVisit Our Web Site:https://www.infiniumglobalresearch.com

View original content:http://www.prnewswire.com/news-releases/artificial-intelligence-in-diabetes-management-industry-to-generate-revenues-of-over-1-26-billion-by-2024---infinium-global-research-301022814.html

SOURCE Infinium Global Research

Read this article:
Artificial Intelligence in Diabetes Management Industry to Generate Revenues of Over $1.26 Billion by 2024 - Infinium Global Research - Benzinga